statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sanofi Reports Increased Total Assets

Sanofi (SNY) has released an update. Sanofi's latest financial release reveals an increase in total assets from 126,464 million at the end of 2023...

Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand

Sanofi reports a 7.8% YoY sales increase in Q2, with sales reaching $11.57 billion, beating consensus. Key highlights include a 29.2% rise in Dupixent sales and a stable 2024 business EPS...

Futures Drop As Japan, European Stocks Tumble On AI Bubble Bursting Fears

Futures Drop As Japan, European Stocks Tumble On AI Bubble Bursting Fears

 US equity futures are lower but well off their worst levels, after a rout in Japan sent the Nikkei tumbling...

Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants

Merck shares topline results from its Phase 2b/3 trial of clesrovimab, showing efficacy in reducing RSV-related infections in infants. Clesrovimab met safety and efficacy endpoints.
read more...

Sanofi's Dupixent: A New Era in COPD Treatment

Sanofi (SNY) has released an update. Sanofi has announced the European Medicines Agency's approval of Dupixent, the first targeted therapy for adul...

AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife

The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market.
read more...

Key Events This Week: Core PCE, GDP, And Lots Of Earnings

Key Events This Week: Core PCE, GDP, And Lots Of Earnings

 As we head into another week full of unknowns, DB's Jim Reid notes this morning that one question that we don't need to ask...

J.P. Morgan Sticks to Its Hold Rating for Sanofi (SNYNF)

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF Research Report) today and set a price target of 98.00. The company...

Sanofi's $20B Consumer Health Unit Sale: Goldman Sachs, Morgan Stanley Line Up $6.5B Financing

Explore the 6 billion financing effort by banks for Sanofi's consumer health division sale. Discover the latest in high-stakes pharmaceutical industry deals.
read more...

Sanofi ships U.S. influenza vaccines for the 2024/25 season

Sanofi ships U.S. influenza vaccines for the 2024/25 season Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire BRIDGEWATER, N.J., July 10, 2024 Customers will start receiving...

Engages in the research, production and distribution of pharmaceutical products

Volume	1.99M
52-Wk High	$55.72
52-Wk Low	$42.63

SNY Sanofi-Aventis

About

Feed

News

Sentiment

Fundamentals